/Tech2h ago

New donation-backed initiative launches to eliminate respiratory diseases by funding Phase 2 preventatives and far-UVC air-cleaning systems

Story Overview

A donation-driven effort is directing philanthropic capital toward equity stakes and grants in broad-spectrum respiratory preventatives already approaching Phase 2, while also backing validation work on far-UVC fixtures meant to disinfect shared indoor air. The goal is framed ambitiously as shrinking everyday respiratory threats to the rarity level now seen with measles, though concrete totals, timelines, and recipient breakdowns are not yet public.

0701312

#990

Original post

Vincent Weisser@vincentweisser#990inTech

@_sholtodouglas legendary work

Sholto Douglas@_sholtodouglas

I (and a bunch of my colleagues) donated to this. I think it is a really excellent initiative. TLDR: - Equity investments in broad spectrum preventatives that are ready to get to phase 2 within 4 years - Grants for basic research that isn't yet ready for commercial viability - Prove out air cleaning tech (like far-uvc), and make it extremely obvious whether it should be adopted in schools, workplaces etc.

1:04 AM · Jun 25, 2026 · 197 Views

Open Question

Amounts and recipients stay unspecified

No pledge sizes, overall target, or named organizations receiving the money have surfaced, leaving the split between vaccine-style preventatives and hardware deployment an open variable for anyone tracking marginal impact.

Donor Profile

AI infrastructure founder adds his name

Vincent Weisser of Prime Intellect has publicly endorsed the push, consistent with his habit of logging small early gifts to underfunded biosecurity ideas, yet the size or timing of any fresh commitment from him remains unstated.

Sentiment

Sentiment building, check back later.

Cluster Engagement

Digg Deeper

No Digg Deeper questions have been answered for this story yet.

Posts from X

Most Activity

VIEWS118BOOKMARKS1LIKES5

Ege Erdil@EgeErdil2

@_sholtodouglas hopefully one day people will look back on the flu the way we today look back on measles

Sholto Douglas@_sholtodouglas

Why we found this a good project to back: It is an incredibly noble goal (end respiratory disease) - with extremely diffuse benefits that are hard to capture (so tricky for existing captial markets), with specific uses of money (fund/prove out xyz tech categories). In the best case - it becomes self sustaining because the equity investments are right, but it doesn't need to be if that'll be the most effective use of the capital for the goal.

2h11851